NCT02001389View on ClinicalTrials.gov

Study of EVP-6308 to Assess the Dose- and Concentration-dependent Displacement of [18F]MNI-659 by EVP-6308

PHASE1CompletedINTERVENTIONAL
Enrollment

14

Participants

Timeline

Start Date

October 31, 2013

Primary Completion Date

June 30, 2014

Conditions
Healthy
Interventions
DRUG

EVP-6308

Arms 1, 2, 3, 4

Trial Locations (1)

Unknown

New Haven

Sponsors
All Listed Sponsors
lead

FORUM Pharmaceuticals Inc

INDUSTRY